Back to Journals » Drug Design, Development and Therapy » Volume 14
Hypothesis
Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,140 | Dovepress* | 7,094+ | 1,337 | 8,431 | |
PubMed Central* | 1,046 | 246 | 1,292 | ||
Totals | 8,140 | 1,583 | 9,723 | ||
*Since 6 July 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 0 | 8 |
View citations on PubMed Central and Google Scholar